Neogen (NEOG) FCF Margin (2010 - 2026)
Neogen's quarterly FCF Margin came in at 5.24% in Q1 2026, up 1133.0% year-on-year from 0.43% in Q1 2025, and up 51.53% quarter-over-quarter from 3.46% in Q4 2025.
Neogen has reported FCF Margin for 17 years, with the latest figure at 5.24% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1133.0% year-over-year to 5.24%; the trailing twelve-month figure through Feb 2026 stood at 0.69% (up 557.0% YoY), and the FY2025 full-year result was 5.18%, up 306.0% from the prior year.
- FCF Margin for Q1 2026 stood at 5.24%, up from 3.46% in the prior quarter.
- The five-year high for FCF Margin was 27.07% in Q2 2023, with the low at 27.24% in Q1 2024.
- Average FCF Margin over 5 years is 4.05%, with a median of 3.33% recorded in 2023.
- Year-over-year, FCF Margin slumped 3759 bps in 2022 and jumped 2147 bps in 2023.
- Tracing NEOG's FCF Margin over 5 years: stood at 13.4% in 2022, then soared by 72 bps to 3.79% in 2023, then surged by 364 bps to 9.99% in 2024, then plunged by 65 bps to 3.46% in 2025, then jumped by 52 bps to 5.24% in 2026.
- The last three FCF Margin figures came in at 5.24% (Q1 2026), 3.46% (Q4 2025), and 6.29% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn | 5.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 5.24% |
| Nov 30, 2025 | 3.46% |
| Aug 31, 2025 | -6.29% |
| May 31, 2025 | 0.15% |
| Feb 28, 2025 | -6.09% |
| Nov 30, 2024 | 9.99% |
| Aug 31, 2024 | -25.97% |
| May 31, 2024 | 1.05% |
| Feb 29, 2024 | -27.24% |
| Nov 30, 2023 | -3.79% |
| Aug 31, 2023 | -3.33% |
| May 31, 2023 | 27.07% |
| Feb 28, 2023 | -14.76% |
| Nov 30, 2022 | -13.40% |
| Aug 31, 2022 | -20.51% |
| May 31, 2022 | 5.60% |
| Feb 28, 2022 | -0.05% |
| Nov 30, 2021 | 10.66% |
| Aug 31, 2021 | 17.08% |
| May 31, 2021 | 11.50% |
| Feb 28, 2021 | 2.82% |
| Nov 30, 2020 | 13.52% |
| Aug 31, 2020 | 19.10% |
| May 31, 2020 | 16.41% |
| Feb 29, 2020 | 16.28% |
| Nov 30, 2019 | 9.66% |
| Aug 31, 2019 | 17.01% |
| May 31, 2019 | 16.48% |
| Feb 28, 2019 | 5.35% |
| Nov 30, 2018 | 10.92% |
| Aug 31, 2018 | 14.22% |
| May 31, 2018 | 16.56% |
| Feb 28, 2018 | 13.99% |
| Nov 30, 2017 | 2.72% |
| Aug 31, 2017 | 15.13% |
| May 31, 2017 | 13.67% |
| Feb 28, 2017 | 10.04% |
| Nov 30, 2016 | 8.42% |
| Aug 31, 2016 | 147.63% |
| May 31, 2016 | 4.71% |
| Feb 29, 2016 | 4.98% |
| Nov 30, 2015 | 11.64% |
| Aug 31, 2015 | 5.05% |
| May 31, 2015 | 9.62% |
| Feb 28, 2015 | 11.62% |
| Nov 30, 2014 | 15.70% |
| Aug 31, 2014 | 11.71% |
| May 31, 2014 | 0.46% |
| Feb 28, 2014 | 5.77% |
| Nov 30, 2013 | 4.65% |
| Aug 31, 2013 | 5.92% |
| May 31, 2013 | 8.48% |
| Feb 28, 2013 | 9.70% |
| Nov 30, 2012 | 10.73% |
| Aug 31, 2012 | 5.07% |
| May 31, 2012 | 15.34% |
| Feb 29, 2012 | 11.44% |
| Nov 30, 2011 | 6.14% |
| Aug 31, 2011 | -11.99% |
| May 31, 2011 | 5.59% |
| Feb 28, 2011 | 5.85% |
| Nov 30, 2010 | 14.03% |
| Aug 31, 2010 | 23.23% |